FDA.reportPublic FDA data

pomalidomide 3 MG Oral Capsule

RxCUI
1369730
RxNorm name
pomalidomide 3 MG Oral Capsule
Display name
pomalidomide 3 MG Oral Capsule
Full name
pomalidomide 3 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PomalidomidePOMALIDOMIDEApotex Corp.b1a1c713-d23b-5ede-1ae0-0bbba47221df2026-03-11Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1369730
PomalidomidePOMALIDOMIDEBreckenridge Pharmaceutical, Inc.41400b90-b64e-447b-90f3-1cad58050eba2026-03-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1369730
PomalidomidePOMALIDOMIDECamber Pharmaceuticals, Inc.52676691-e171-467c-ae55-b5dcc14062a42026-03-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1369730
PomalidomidePOMALIDOMIDEAurobindo Pharma Limited1539fbf9-8281-4c7b-827b-9f53b50d90422026-01-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1369730
PomalidomidePOMALIDOMIDENatco Pharma Limited0169dbda-53df-4cd9-b989-ff7544f1bdf52025-11-18Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1369730
PomalidomidePOMALIDOMIDETeva Pharmaceuticals, Inc.dee932c5-0c7c-45f0-b2bb-c027badee5372025-10-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1369730
PomalystPOMALIDOMIDECelgene Corporation2b25ef01-5c9e-11e1-b86c-0800200c9a662025-02-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1369730

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
2b25ef01-5c9e-11e1-b86c-0800200c9a66pomalidomide 3 MG Oral CapsulePSN26These highlights do not include all the information needed to use POMALYST safely and effectively. See full prescribing information for POMALYST. POMALYST ® (pomalidomide) capsules, for oral use Initial U.S. Approval: 201320250226
2b25ef01-5c9e-11e1-b86c-0800200c9a66pomalidomide 3 MG Oral CapsuleSCD26These highlights do not include all the information needed to use POMALYST safely and effectively. See full prescribing information for POMALYST. POMALYST ® (pomalidomide) capsules, for oral use Initial U.S. Approval: 201320250226
41400b90-b64e-447b-90f3-1cad58050ebapomalidomide 3 MG Oral CapsuleSCD10These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES. POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 201320260304
41400b90-b64e-447b-90f3-1cad58050ebapomalidomide 3 MG Oral CapsulePSN10These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES. POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 201320260304
b1a1c713-d23b-5ede-1ae0-0bbba47221dfpomalidomide 3 MG Oral CapsuleSCD2These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES . POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 201320260311
b1a1c713-d23b-5ede-1ae0-0bbba47221dfpomalidomide 3 MG Oral CapsulePSN2These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES . POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 201320260311
52676691-e171-467c-ae55-b5dcc14062a4pomalidomide 3 MG Oral CapsulePSN2These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES. POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 201320260304
52676691-e171-467c-ae55-b5dcc14062a4pomalidomide 3 MG Oral CapsuleSCD2These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES. POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 201320260304
dee932c5-0c7c-45f0-b2bb-c027badee537pomalidomide 3 MG Oral CapsuleSCD1These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES . POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 201320260302
dee932c5-0c7c-45f0-b2bb-c027badee537pomalidomide 3 MG Oral CapsulePSN1These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES . POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 201320260302
1539fbf9-8281-4c7b-827b-9f53b50d9042pomalidomide 3 MG Oral CapsulePSN1These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES. POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 201320260130
1539fbf9-8281-4c7b-827b-9f53b50d9042pomalidomide 3 MG Oral CapsuleSCD1These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES. POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 201320260130
0169dbda-53df-4cd9-b989-ff7544f1bdf5pomalidomide 3 MG Oral CapsulePSN1These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES. POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 201320251118
0169dbda-53df-4cd9-b989-ff7544f1bdf5pomalidomide 3 MG Oral CapsuleSCD1These highlights do not include all the information needed to use POMALIDOMIDE CAPSULES safely and effectively. See full prescribing information for POMALIDOMIDE CAPSULES. POMALIDOMIDE capsules, for oral use Initial U.S. Approval: 201320251118